EBV-immortalized isogenic human B-cell clones exhibit differences in DNA-protein complex formation on the BZLF1 and BRLF1 promoter regions among latent, lytic and TPA-activated cell lines

Virus Research

Volumn 31, Issue 1, 1994, Pages 89-107

  Hui, Cen ^a   McKnight, Jennifer L C ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Herpesviruses; Oncogenesis; Transcription factor

Indexed keywords

BUTYRIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; VIRUS REACTIVATION;

B-LYMPHOCYTES; BASE SEQUENCE; BINDING, COMPETITIVE; CELL LINE, TRANSFORMED; CELL NUCLEUS; DNA, VIRAL; DNA-BINDING PROTEINS; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMAN; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; OLIGODEOXYRIBONUCLEOTIDES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; VIRUS ACTIVATION; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 0028089181     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1702(94)90073-6     Document Type: Article

References (47)

1. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
2. Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame (BHRF1) in latently and lytically infected B lymphocytes
3. IP-1: A dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation
4. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
5. Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4
6. Evidence for restricted Epstein Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with post-transplant lymphoproliferative disorders
7. The Epstein Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimeriza- tion domain that lacks the characteristic heptad leucine zipper motif
8. Functional limits of OriP, the Epstein-Barr virus plasmid origin of replication
9. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma
10. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators
11. Activation of expression of a latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA
12. fos and jun: the AP-1 connection
13. Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA
14. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
15. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis
16. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1
17. The Epstein-Barr virus origin of plasmid replication, OriP, contains both the initiation and termination sites of DNA replication
18. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions
19. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr vial infection to productive infection in lymphoid cells
20. Cross-family dimerization of transcription factors Fos/Jun and ATF/ CREB alters DNA binding specificity
21. Identification and characterization of OriLyt, a lytic origin of DNA replication of Epstein-Barr virus
22. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner
23. Synchronous and sequential activation of latently infected Epstein-Barr virus genome
24. Viral latency and transformation: the strategy of Epstein-Barr virus
25. Leucine zippers of fos, jun, and GCN4 dictate dimerization specificity and thereby control DNA binding
26. Epstein-Barr virus and its replication
27. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate
28. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromasomal persistence of Epstein-Barr virus derived plasmids in human cells
29. Induction of replication of Epstein-Barr virus DNA by 12-O-tetradecanoyl-phorbol-13-acetate. II. Inhibition by retinoic acid and 9-(2-hydroxyetho- xymethyl) guanine
30. Epstein-Barr virus bicistronic mRNAS generated by facultative splicing code for two transcriptional trans-activators
31. Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP induced gene transcription
32. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an API binding site
33. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
34. DNA of Epstein-Barr virus. VIII. B95.8, the previous prototype, is an unusual deletion derivative
35. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1
36. Bidirectional transcription of the Epstein-Barr virus major internal repeat
37. Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhance elements
38. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases
39. Retinoic acid is a negative regulator of AP-1-responsive genes.
40. Pathways of activation of the Epstein-Barr virus productive cycle
41. trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of EBV DNA fragment
42. The Epstein Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 sites
43. Induction of anti-EBNA1 protein by 12-0-tetrade-canoylphorbol-13-acetate treatment of human lymphoblastoid cells
44. Mutiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within OriP of Epstein-Barr virus
45. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
46. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor
47. Persisting oncogenic herpesvirus induced by the tumor promoter TPA